<ѻý>COVID Outcomes Worse for MS Patients With Mobility Problemsѻý> North American study also finds higher risk with certain treatments Mar 19, 2021
<ѻý>PML Reported in Ocrelizumab-Treated MS Patientѻý> Case raises questions about treatments for older people with multiple sclerosis Mar 16, 2021
<ѻý>Real-World Study Shows MS Patients Have High Infection Risksѻý> Urinary, kidney infections especially are more common for people with MS than others Mar 02, 2021
<ѻý>Juggling COVID Vax, MS Therapies Proves Challengingѻý> The issue: some multiple sclerosis drugs may attenuate antibody responses to vaccination Mar 01, 2021
<ѻý>Worse COVID-19 Outcomes Tied to MS Disability, Ageѻý> North American data echoes findings from around the world Feb 28, 2021
<ѻý>Multiple Sclerosis and Depression: Are Links Causal?ѻý> Mendelian randomization study says no, but predisposition to obesity may play a role Feb 28, 2021
<ѻý>Blood Biomarker Linked with MS Disability, Brain Atrophyѻý> Diabetes, smoking, BMI may influence serum NfL, real-world study suggests Feb 27, 2021
<ѻý>Telemedicine Gets Thumbs Up, MS Specialists Sayѻý> Most providers want to keep using it, but limitations need to be resolved Feb 27, 2021
<ѻý>Sleep-Dementia Link; Neanderthal Mini-Brains; MS Tx and COVID Vaxѻý> News and commentary from the world of neurology and neuroscience Feb 16, 2021
<ѻý>Study Reassures on MS Patients' Breast, Colorectal Cancer Riskѻý> But higher incidence of other cancers in Canadian data Nov 25, 2020
<ѻý>Pregnancies, Later Menopause Tied to Progressive MS Onset Ageѻý> Pregnancies may have a dose effect on delaying progressive MS Nov 23, 2020
<ѻý>Long-Term Ocrelizumab Benefits Seen in PPMSѻý> No new safety signals, but more research needed about anti-CD20 drugs and COVID-19 Nov 02, 2020
<ѻý>Some MS Drugs Linked With Worse COVID-19 Outcomesѻý> Registry data looks at risks of hospitalization, ICU admission, ventilation Sep 28, 2020
<ѻý>COVID-19 Hits Black MS Patients Hardѻý> COViMS registry gives first look at outcomes among North American patients Sep 28, 2020
<ѻý>Masitinib Shows Positive Signs in Progressive MSѻý> Tyrosine kinase inhibitor targets innate immune system Sep 14, 2020
<ѻý>Depression, Suicidal Thoughts Prevalent in MSѻý> Burden equally high in relapsing-remitting and progressive multiple sclerosis Sep 13, 2020
<ѻý>Can Tau Predict Early MS Disability?ѻý> Multiple sclerosis patients with higher baseline tau had worse prognosis, longitudinal study shows Sep 12, 2020
<ѻý>Dementia Tied to Olfaction; Preclinical Alzheimer's Trial; Guillain-Barré and COVID-19ѻý> News and commentary from the world of neurology and neuroscience Jul 21, 2020
<ѻý>The Serious Conversation: Delivering Bad News by Telemedicineѻý> As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<ѻý>Muddy Results for MS Hookworm Therapyѻý> No significant benefit on MRI, but T regulatory cells increased Jun 15, 2020
<ѻý>Air Quality Tied to MS Riskѻý> Multiple sclerosis was more prevalent in Italian areas with more pollution May 29, 2020
<ѻý>Ozanimod Treatment Duration and Infection Riskѻý> Zoster rates low, but rising with time May 21, 2020
<ѻý>MOG Antibodies Tied to More Pediatric Conditionsѻý> "Major surprise" seen in children with encephalitis Feb 11, 2020
<ѻý>Neurology Patients Have Higher Suicide Ratesѻý> While suicide is rare, some disorders carry five times more risk Feb 04, 2020
<ѻý>Your Brain on Psilocybin; Probiotics and Parkinson's; Alzheimer's Signalingѻý> News and commentary from the world of neurology and neuroscience Jan 21, 2020
<ѻý>Despite New Generic, MS Drug Costs Nearly Triple in 7 Yearsѻý> Generic glatiramer acetate "had a minimal effect on prices overall" Jan 15, 2020
<ѻý>Serum NfL Levels May Indicate MS Prodromal Phaseѻý> Study shows elevated neurofilament light levels 6 years before MS onset Sep 16, 2019
<ѻý>Ofatumumab Cuts MS Relapse Rates, New Brain Lesionsѻý> Anti-CD20 monoclonal antibody poised to take on ocrelizumab Sep 16, 2019
<ѻý>Ponesimod Bests Aubagio in Head-to-Head MS Trialѻý> Investigational drug reduces annual relapse rate, shows effects on fatigue Sep 12, 2019
<ѻý>IL-6 Inhibitor Cuts NMO Relapse Ratesѻý> Satralizumab reduces attacks in neuromyelitis optica spectrum disorder Sep 11, 2019
<ѻý>Chronic, Active Lesions Tied to More Aggressive MSѻý> Smoldering inflammation seen even in patients treated with effective disease-modifying therapies Aug 12, 2019
<ѻý>Early MS Scans Predict Long-Term Outcomesѻý> MRI lesions seen 15 years prior linked to secondary progression and disability Jul 26, 2019
<ѻý>2019: 'The Year of NMO'ѻý> Three different drugs report lower relapse rates in neuromyelitis optica spectrum disorder May 10, 2019
<ѻý>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time?ѻý> Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<ѻý>Sugary Drinks May Up Disability in MSѻý> But overall diet quality not associated with disability status Mar 05, 2019
<ѻý>Can MS Treatment Be Stopped?ѻý> Pendulum keeps swinging on risks from drug discontinuation Mar 04, 2019
<ѻý>Alemtuzumab Benefits Persist in Multiple Sclerosisѻý> Many patients did not need additional treatment after first two courses of the drug Mar 03, 2019
<ѻý>Early Serum NfL Tied to Long-Term MS Brain Changesѻý> Early axonal damage may identify multiple sclerosis patients at risk for more severe disease Mar 01, 2019
<ѻý>Study Raises Questions on Nuedexta Prescribingѻý> Real-world data show PBA drug given mainly to dementia and Parkinson's disease patients Jan 07, 2019